News

US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease: Paris Thursday, June 5, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ( ...
Dr. Alicia Morgans discussed complications associated with ADT in prostate cancer, and how men can still maintain quality of ...
Over the past five or 10 years, methylene blue has come to be touted online as a so-called nootropic agent – a substance that ...
Sanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.
Why is it that fish is so good for you? My husband and I have been thinking about adding more of it to our diets, but we keep ...
Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...
In-Depth MemoDefend Review Reveals Ingredient Science, Real User Results, Pricing Breakdown, and Long-Term Brain Health ...
Biohacker Bryan Johnson had earlier taken plasma from his son. He has now done a total plasma exchange which involves removing all blood, and substituting plasma with albumin and antibodies ...
Learn if cat dandruff is normal, its causes, and how to treat it. Our ultimate guide provides insights into feline skin ...
Consuming an abundance of protein can lead to digestive issues like constipation or diarrhea, while high-protein diets that ...
Anemia is a major global health concern, particularly affecting women of childbearing age, with prevalence rates between ...